A UCF researcher has combined cutting-edge nanoscience with a magnetic phenomenon discovered more than 170 years ago to create a method for speedy medical tests.
The discovery, if commercialized, could lead to faster test results for HIV, Lyme disease, syphilis, rotavirus and other infectious conditions.
“I see no reason why a variation of this technique couldn’t be in every hospital throughout the world,” said Shawn Putnam, an assistant professor in the University of Central Florida’s College of Engineering & Computer Science.
At the core of the research recently published in the academic journal Smallare nanoparticles – tiny particles that are one-billionth of a meter. Putnam’s team coated nanoparticles with the antibody to BSA, or bovine serum albumin, which is commonly used as the basis of a variety of diagnostic tests.
By mixing the nanoparticles in a test solution – such as one used for a blood test – the BSA proteins preferentially bind with the antibodies that coat the nanoparticles, like a lock and key.
That reaction was already well known. But Putnam’s team came up with a novel way of measuring the quantity of proteins present. He used nanoparticles with an iron core and applied a magnetic field to the solution, causing the particles to align in a particular formation. As proteins bind to the antibody-coated particles, the rotation of the particles becomes sluggish, which is easy to detect with laser optics.
The interaction of a magnetic field and light is known as Faraday rotation, a principle discovered by scientist Michael Faraday in 1845. Putnam adapted it for biological use.
“It’s an old theory, but no one has actually applied this aspect of it,” he said.
Other antigens and their unique antibodies could be substituted for the BSA protein used in the research, allowing medical tests for a wide array of infectious diseases.
The proof of concept shows the method could be used to produce biochemical immunology test results in as little as 15 minutes, compared to several hours for ELISA, or enzyme-linked immunosorbent assay, which is currently a standard approach for biomolecule detection.
Receive an email update when we add a new BIOCHEMICAL IMMUNOLOGY TEST article.
The Latest on: Biochemical immunology test
via Google News
The Latest on: Biochemical immunology test
- Prokaryotic Metabolism and Physiologyon July 29, 2021 at 6:14 pm
Determination of genome sequences for a wide range of bacteria and archaea now requires an in-depth knowledge of prokaryotic metabolic function to give biochemical, physiological and ecological ...
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosison July 23, 2021 at 5:00 pm
3 Department of Pathology and Immunology, Washington University School of Medicine ... Statistical differences were calculated by Mann-Whitney U test. **P
- Human Nutrition with placement yearon July 23, 2021 at 4:52 pm
Coursework can take many forms, for example: essay, report, seminar paper, test, presentation ... This module discusses the biochemical roles of the essential nutrients in metabolism, the possible ...
- A variable-gain stochastic pooling motif mediates information transfer from receptor assemblies into NF-κBon July 23, 2021 at 3:36 pm
2 Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, PA 15260, USA. 3 Center for Systems Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. ↵† ...
- 'Good cholesterol' may protect liveron July 21, 2021 at 5:01 pm
Randolph, Ph.D., the Emil R. Unanue Distinguished Professor of Immunology. "But our study suggests that raising levels of this specific type of HDL, and specifically raising it in the intestine ...
- Microbiology and Immunology 2018on July 21, 2021 at 5:01 pm
Our 4th Annual Microbiology and Immunology Virtual Conference is now available On Demand! Participants will explore and discover new concepts, tools and techniques to apply to ongoing research and ...
- Breaking News: Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharmaon July 19, 2021 at 6:28 am
Todos now validating cPass in its highly automated Provista Diagnostics CLIA/CAP lab to enable antibody quantitation, high throughput and fast turnaround times Todos Medical, Ltd. (OTCQB: TOMDF), a ...
- New COVID-19 vaccine candidate, option for low- to mid-income countrieson July 15, 2021 at 7:29 am
Results from the study, which applied lessons learned from the hepatitis B vaccine platform technology, are published online today in Science Immunology. Researchers from the Yerkes National Primate ...
- Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitoron July 14, 2021 at 5:00 pm
Thus, we first tested the 60-IU dose of CSL830 versus low-volume placebo, and only if the null hypothesis was rejected at an alpha level of 0.05 did we test the 40-IU dose versus high-volume placebo.
via Bing News